Finance

Lists
LTGO:NASDAQ
Latigo Biotherapeutics Ord Shs
$22.15
+2.83%
(+0.61) 1D
$22.15
0.00% (0.00)
After hours
Closed: Sep 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LTGO...
Open
$21.76
High
$23.22
Low
$21.50
Avg. vol.
284.51K
Volume
178.71K
52-wk high
$25.90
52-wk low
$17.22
No. of employees
66
Open
$21.76
High
$23.22
Low
$21.50
Avg. vol.
284.51K
Volume
178.71K
52-wk high
$25.90
52-wk low
$17.22
No. of employees
66
About Latigo Biotherapeutics Ord Shs
CEO-
Employees66
Founded2018
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to LTGO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for LTGO in the last 3 months.
Highest
Current $22.15
$73.00 (+229.57%)
Average
$57.67 (+160.36%)
Lowest
$50.00 (+125.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yatin Suneja
Guggenheim
Buy
Initiated
$50.00
+125.7%
09/01/2026
Akash Tewari
Jefferies
Buy
Initiated
$50.00
+125.7%
09/01/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
$73.00
+229.6%
09/03/2026
Awaiting results...
Call Time: Thu, Sep 3, 4:00 PM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -$0.81
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18.69M
22.92M
17.63M
21.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.82M
2.82M
5.80M
4.58M
Operating expense
21.51M
25.74M
23.44M
25.81M
Total operating expenses
21.51M
25.74M
23.44M
25.81M
Operating income
-21.51M
-25.74M
-23.44M
-25.81M
Other non operating income
43.00K
-958.00K
1.00K
-2.00K
EBT including unusual items
-20.95M
-25.84M
-22.96M
-25.80M
EBT excluding unusual items
-20.95M
-25.84M
-22.96M
-25.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.95M
-25.84M
-22.96M
-25.80M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
517.00K
868.00K
474.00K
264.00K
Interest expense
-
-
-
-251.00K
Net interest expenses
517.00K
868.00K
474.00K
13.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.44M
-25.68M
-23.39M
-25.76M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps